• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Keystone Heart

Keystone Heart acquires 510 Kardiac Devices

June 16, 2020 By Danielle Kirsh

Keystone Heart today said it has acquired 510 Kardiac Devices for an undisclosed amount. The development-stage 510 Kardiac Devices is currently developing the Lim Transseptal System to meet the demands of left-sided structural heart procedures that require a transeptal approach. The system is important in procedures such as percutaneous treatment of mitral valve disease, percutaneous […]

Filed Under: Business/Financial News, Cardiovascular, Mergers & Acquisitions Tagged With: 510 Kardiac Devices, Keystone Heart

Keystone Heart cerebral embolic protection device wins CE Mark

March 10, 2020 By Danielle Kirsh

Keystone Heart this week said it won CE mark approval for its TriGuard 3 Cerebral Embolic Protection device. TriGuard 3 is designed to reduce the risk of cerebral damage by deflecting debris from cerebral circulation during trans catheter aortic valve implantation and other transcatheter heart procedures, according to the company. “Even with increased operator experience […]

Filed Under: Cardiovascular, Regulatory/Compliance Tagged With: Keystone Heart

Keystone Heart inks distribution agreement with Vasorum

July 12, 2019 By Chris Newmarker

Keystone Heart has started distributing Ireland-based Vasorum’s Celt ACD vascular closure device in the U.S. and Europe, effective this month. Approved by FDA in 2016, the Celt ACT is a biocompatible implant meant to close femoral artery punctures taking place after catheterization. Health providers have implanted the CeltACT in more than 40,000 patients to date. […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Distribution, News Well Tagged With: Keystone Heart, Vasorum, Venus Medtech

Venus Medtech completes Keystone Heart merger

December 26, 2018 By Sarah Faulkner

Chinese transcatheter heart valve maker Venus Medtech said today that it closed its merger with Keystone Heart. Privately-held Keystone Heart sells TriGuard embolic protection devices that are designed to protect the brain during transcatheter aortic valve replacement and other cardiac procedures. Hoping for FDA approval in the third quarter of 2019, Keystone Heart is enrolling patients […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Featured, Mergers & Acquisitions, Vascular Tagged With: Keystone Heart, Venus Medtech

Venus Medtech to acquire Keystone Heart

September 25, 2018 By Fink Densford

Chinese heart valve maker Venus Medtech said today it inked a deal to acquire cerebral embolic protection device maker Keystone Heart for an undisclosed amount. Tampa, Fla.-based Keystone Heart developed and produces TriGuard embolic protection devices, which are designed to protect the brain from emboli during transcatheter aortic valve replacement and other heart procedures to reduce […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Mergers & Acquisitions, Vascular Tagged With: Keystone Heart, Venus Medtech

Keystone Heart launches new TriGuard embolic protection study

May 31, 2018 By Fink Densford

Keystone Heart said today it launched the second phase of its Reflect trial evaluating the safety and efficacy of its third-generation TriGuard cerebral embolic protection device. In the trial, investigators will explore the use of the TriGuard 3 and its ability to protect a patient’s brain from emboli during transcatheter aortic valve replacement procedures, the […]

Filed Under: Cardiovascular, Clinical Trials, Neurological, Vascular Tagged With: Keystone Heart

Venus Medtech inks exclusive TriGuard 3 deal with Keystone Heart

May 24, 2018 By Fink Densford

Chinese heart valve maker Venus Medtech said yesterday it inked a partnership deal with Keystone Heart through which Venus will gain exclusive rights to develop and sell a third-gen version of Keystone’s TriGuard 3 device in China and other Asian markets. The deal builds on a partnership between the two companies announced last March to promote Venus’ […]

Filed Under: Business/Financial News, Neurological, Replacement Heart Valves, Research & Development Tagged With: Keystone Heart, Venus Medtech

Keystone Heart looks to launch 3rd-gen TriGuard trials in 2017

August 2, 2017 By Fink Densford

Keystone Heart  said yesterday it plans to launch a clinical trial of a 3rd-generation TriGuard cerebral embolic protection device by the end of the year. The Israel-based company said the new device, dubbed the TriGuard 3, will offer technological improvements over previous versions of the device, and that it has accelerated the development program of […]

Filed Under: Blood Management, Clinical Trials, Neurological, Research & Development Tagged With: Keystone Heart

Keystone Heart, Venus Medtech ink Asian TAVR stroke partnership deal

March 2, 2017 By Fink Densford

Keystone Heart and Chinese heart valve maker Venus Medtech said today they inked a partnership deal covering China and other Asian markets. Through the deal, the companies will provide Venus Medtech’s transcatheter aortic valve replacement system along with Keystone’s TriGuard cerebral embolic protection device. TriGuard is a cerebral embolic protection device designed to reduce the amount of […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Replacement Heart Valves Tagged With: Keystone Heart, Venus Medtech

Keystone Heart touts TriGuard cerebral protection data in TAVR patients

September 19, 2016 By Fink Densford

Keystone Heart today released data from transcatheter aortic valve replacement patients treated with its TriGuard cerebral embolic protection device, touting a significant reduction in brain lesions. TriGuard is a cerebral embolic protection device designed to reduce the amount of embolic material entering blood circulation to the brain during TAVR procedures, by allowing blood to pass […]

Filed Under: Clinical Trials, Neurological, Replacement Heart Valves, Vascular Tagged With: Keystone Heart, Stroke

TAVI: Good early data for Keystone Heart’s TriGuard

June 2, 2015 By Fink Densford

Data from a trial of Keystone Heart‘s TriGuard anti-stroke device showed a lower rate of neurologic deficits after transcatheter aortic valve implantation, according to research presented last month at EuroPCR 2015 in Paris. The 85-patient Deflect 3 study found that TAVI patients treated with the Israeli company’s TriGuard, which is designed to allow blood to […]

Filed Under: Cardiovascular, Neurological, Replacement Heart Valves Tagged With: Keystone Heart, TAVI

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS